• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Paragon Medical

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Paragon Medical

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Funding New Ideas or Innovation

    ...

    Funding New Ideas or Innovation
    Related CONTENT
    • MedWorld Advisors
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    • MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    • Babson Diagnostics Raises $31 Million in Series B Funding
    • Presidio Medical Names Michael Onuscheck as CEO
    Marissa Fayer, President, Fayer Consulting LLC; CEO, HERHealthEQ; and Partner, LLEX Partners04.03.18
    Everyone has the next big new idea, and in medtech, they don’t come cheap. But companies also don’t have to be valued in the billions of dollars to make an impact or get an idea moving forward.  

    The funding environment is highly regulated and will continue to be into the foreseeable future, as it protects the consumers from monopolies and obscene prices (above and beyond what the medical technology industry is used to). This atmosphere has allowed investors to get creative with finding capital and to expand existing funding vehicles. In the past several years, alternate versions of sourcing have become more prevalent for devices and technology, which previously have been kept in the shadows or for “those in the know.”

    Finding capital for new ideas and innovation can come in many shapes and sizes; there is not a one-stop shop or way to complete it. Many innovations use each of the capital raising tools listed below to move from early stage (often non-traditional) to traditional funding, but others raise capital solely from traditional funding. There are others, of course, that completely skip traditional funding methods and raise capital in non-conventional ways. Most medtech companies fund new ideas and innovation through acquisition or initial public offerings (IPOs).  There is no right way, except what feels right for company management, culture, and shareholders.
    Traditional sources of medtech funding include:

    • Venture Capital: Typically investing in deals in the range of $10 million to $50 million, with a turn rate of two to four years with at least a five-fold increase in value. Venture capital is investing equity into a company and looks to partner with the entrepreneur to help grow and manage risk. There needs to be a significant increase in the value of the business in a short amount of time.
    • Private Equity: Typically investing after venture capital (VC), often buying from VC firms once the companies have entered their growth stage. Private equity (PE) deals typically range from $25 million to $300 million, are retained for an average of three to seven years, and expect at least a five-fold growth rate, depending on the amount invested. In the medical technology space, PE firms look to solidify the growth of the company, position it for a strategic sale, or determine the strategic value the technology can have within certain sectors. The company is growth positive and showing a profit, which allows for continued profits and growth while reinvesting back into the business for development. This is often the stage that a medtech company is in before going public.

    As general innovation around the world continued to grow over the last two decades, the money spent on medical technology continued to decrease. Medtech’s share of venture capital fell from 13 percent in 1992 to just 4 percent in 2014, according to an Advanced Medical Technology Association (AdvaMed) report released in October 2016. Ashley Wittorf, executive director of AdvaMed Accel, said in a statement accompanying the report, “This report lays out in stark terms the challenges facing not only medtech startups, but the entire ecosystem that supports innovation in our industry.” This created the need to progress the structures that were working behind the scenes to become more mainstream.

    Among the non-traditional sources of funding are:

    • Angel investments: This is also known as seed funding and/or the family and friends round of funding. Its value can range from $100 to an amount of the contributor’s choice, typically up to $100,000 per person. The investors don’t necessarily have to be qualified medical professionals and they usually are known to the founders or management team personally. Recently, groups of angels have formed networks to collectively have a larger investing platform, which allows their dollars to go further. Angel investors typically expect a return on investment between 10- and 20-fold.
    • Crowd Funding: On the surface, this method might seem unconventional, but it can be effective. This technique works by raising small sums of money from a large number of people on the Internet. There are two models of crowdfunding that several medtech companies have used successfully. One is a donation-based funding model where people donate toward a business goal based in return for the product or other gifts (i.e., Fisher Wallace Labs’ Kortex on Indiegogo which raised over $200,000 for a new product launch). The other model is investment crowdfunding, in which startups sell ownership stakes online in exchange for equity or debt.
    • Family Offices: Family offices manage the financial and investment side of an affluent individual, family, or group of families and often are directed to invest in specific sectors, such as healthcare or medical technology. In past years, family offices have filled a very important gap within the medtech investing space, as they can provide capital from $1 million up to $50 million and oftentimes higher when they are in a collective with other family offices. This collective is known as a direct investing vehicle (an example is LLEX Partners). Family offices perform their own diligence process, can provide management and leadership if needed, and can either directly invest in a lead or assume a co-investor position at any stage of the innovation, often in the Series A or B round. Family offices are self-directed and in past years have shown double digit returns, while the market and hedge funds have only been performing at 7 percent to 8 percent.
    • Innovation Labs: Healthcare innovation incubators and accelerators worldwide are helping entrepreneurs grow and develop startup companies with funding, mentorship, and investment resources. They provide space, support, and resources for innovation and also work to obtain the necessary funding to take the innovation to the next level. Several labs are application-based and others are pay-for-space models, though many are tied to OEMs who are looking to innovate and create a sustainable source for innovation.

    Finding the Right Capital
    Depending on the type of capital a company and/or idea is looking for usually will dictate the source of the capital. Brand new ideas will naturally start with angel investors, crowd funding, innovation labs, and family offices, as they are the vehicles to fund novel technologies, take the biggest risk, and often produce the highest returns. On average, 70 percent of early-stage medtech deals do not make it past the first round of funding (Seed or Series A). Of those that make it, approximately 50 percent of those close their full Series B round funding, typically with VC or PE firms. 

    There are even more particulars within each funding discipline. Capital is sometimes dependent on geography, sector, and stage (early-, middle-, or late-stage). Each investment firm is also looking for their own unique financing strategy and internal investment criteria. For example, OrbiMed Advisors LLC looks to invest in private and public equity and royalty opportunities within the life sciences sector with a specialty in “innovations that will help ensure humanity lives healthier, longer, and more productive lives.” But within a similar sector, MVC Capital Inc. looks to invest mainly in medical device contract manufacturers specializing in disposables.

    Just as there are lobbyists in Washington to connect companies with policymakers, there are capital consultants that connect medtech companies with the appropriate sources of capital. As in any industry, it’s about the connections, but it’s also about the people who are making the connections and helping finance the deals. Having experts who are medtech industry veterans (or whatever industry the developed idea or technology might be viable for), creates a significant advantage for the technology. It also gives companies an additional team member who is also conversant in the language of both the technology and the financial side.

    Applications for Medtech
    The cyclical growth consolidation nature of medical technology requires a constant stream of new ideas to “feed the beast.” Without new ideas, the industry would come to a halt, and more importantly the patients the industry serves would never see innovation. As the past 30 years have proven, medical technology growth has led innovation within life sciences and has significantly improved the healthcare system and the planet’s overall health.

    Alternate sources of capital, along with digital and connected health platforms, appear to be reversing the trend of reduced medtech capital investment. Thus, innovation that combines medical devices with data collection might be the springboard to wet the appetite for continued future funding. The push for bundled payments and reductions in time and costs will also be significant factors that investors are now keenly aware of at any level of investment. Both consumers and investors are becoming savvier, and the industry now has an opportunity to provide that for them.

    This presents a powerful opportunity for the medtech community to continue innovation while recognizing that it cannot be done alone. Innovation without capital will perpetuate a great idea, but if no one knows about it, how much impact can it make? Capital is a vehicle that can help move innovation from idea to action to impact. 


    Marissa Fayer is an 18-year medtech executive, entrepreneur, and philanthropist whose mission is to advance growth and prosperity for organizations and the communities in which they operate. Fayer is the president of Fayer Consulting LLC, the CEO of the non-profit HERHealthEQ, and a partner at LLEX Partners. Her expertise and vision help life science companies grow with operational excellence and assume the responsibility to bring about a more giving global community with health and opportunity.
    Related Searches
    • advanced medical technology association
    • ceo
    • president
    • indiegogo
    Suggested For You
    MedWorld Advisors MedWorld Advisors
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Presidio Medical Names Michael Onuscheck as CEO Presidio Medical Names Michael Onuscheck as CEO
    Vicarious Surgical Business Combination with D8 Holdings Approved Vicarious Surgical Business Combination with D8 Holdings Approved
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board
    Baxter to Acquire Hillrom in $10.5 Billion Deal Baxter to Acquire Hillrom in $10.5 Billion Deal
    iNitrile iNitrile's Co-Founder Raises $33M for the Company
    Ramin Mousavi Appointed CEO of CathWorks Ramin Mousavi Appointed CEO of CathWorks
    FDA Issues EUA for BD Veritor At-Home Covid-19 Test FDA Issues EUA for BD Veritor At-Home Covid-19 Test
    CVRx Completes First Procedure With Ultrasound-Guided Implant Approach CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    Stanislav Glezer Joins Inogen as Chief Medical Officer Stanislav Glezer Joins Inogen as Chief Medical Officer
    Glaukos Glaukos' PRESERFLO MicroShunt Approved in Australia

    Related Buyers Guide Companies

    • MedWorld Advisors

      MedWorld Advisors

      ...
      Florence Joffroy-Black, CEO/President 11.29.22

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021

      Attendees of The MedTech Conference, powered by AdvaMed, will vote for the Grand Prize winner.
      MedTech Innovator 09.21.21


    • Diagnostics
      Babson Diagnostics Raises $31 Million in Series B Funding

      Babson Diagnostics Raises $31 Million in Series B Funding

      Money will be used to help drive commercialization of customer-first, highly accessible diagnostic blood testing.
      Business Wire 09.20.21

    • Presidio Medical Names Michael Onuscheck as CEO

      Presidio Medical Names Michael Onuscheck as CEO

      New chief executive was an executive committee member and president of Global Businesses and Innovation at Alcon.
      Business Wire 09.17.21

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login